Arclio is a clinical-evidence platform for biopharma. It gives regulatory, clinical, and biostatistics teams FDA-defensible answers from their trial data in 30 seconds, not three days. Unlike tools that only show where a number came from, Arclio proves it correct and unaltered through deterministic, re-runnable computations on a tamper-evident evidence chain. The agent runs entirely inside your own infrastructure — no data ever moves. It produces publication-grade charts and an FDA readiness scorecard across efficacy, safety, data quality, competitive positioning, and biomarkers.
| Website | https://www.arclio.ai/ |
| Employees | 3 (3 on RocketReach) |
| Founded | 2025 |
| Industry | Technology, Information and Internet |
Looking for a particular Arclio employee's phone or email?
Jacques Kotze is the Founder of Arclio.
3 people are employed at Arclio.
Arclio is based in New York, New York.